Feasibility Study of Cylindrically Diffusing 532 nm Wavelength for Treatment of Pancreatic Cancer

다국어 초록 (Multilingual Abstract)

Laser ablation may provide a minimally invasive palliative treatment for pancreatic cancer. The aim of the current study was to assess the feasibility of a 532-nm laser equipped with a cylindrical light diffuser for the treatment of pancreatic cancer. Monolayers of BxPC-3 human pancreatic cancer cell were exposed to 532 nm laser light. Power levels of 5 - 7 W were used to uniformly target the entire cell colonies for 60 and 120 seconds. The cells were incubated for 24 hours after treatment and viabilities were determined by using a MTT assay. Laser ablation was performed by using the cylindrical light diffuser on six pancreatic tumor tissues obtained from pancreatic cancer xenograft mouse models, which were exposed to the 532 nm light at 5W or 7W for 10 to 30 seconds. In the in vitro study, the survival rates of the pancreatic cancer cells were reduced by 6.6% to 98.9% after the treatment, and the survival rates were reduced by increasing laser power and/or irradiation time. In the pancreatic tumor tissues, a homogenous circular ablation zone was observed in all tumors and the ablation distance induced by the laser irradiation showed to be constant from the diffuser to all directions (standard deviation, 0.3 - 1.3 mm). Ablation distance and area increased with increasing laser power and/or irradiation time. The 532 nm laser effectively killed pancreatic cancer cells, and the cylindrical light diffuser was found to be suitable for laser ablation as it provided uniform ablation in pancreatic cancer.

참고문헌 (Reference)

1 R. L. Siegel, 65 : 5-, 2015

2 T. H. Nguyen, 23 : 20829-, 2015

3 P. J. Hosein, 12 : 199-, 2012

4 A. S. Cunha, 201 : 359-, 2005

5 S. Gourgou-Bourgade, 31 : 23-, 2012

6 M. Cantore, 99 : 1083-, 2012

7 S. P. Haen, 2011 : 160250-, 2011

8 C. Pacella, 100 : 3903-, 2015

9 G. Tian, 96 : e6597-, 2017

10 G. Francica, 199 : 1393-, 2012

11 F. Di Matteo, 72 : 358-, 2010

12 V. Arienti, 246 : 947-, 2008

13 C. Rosenberg, 10 : 66-, 1990

14 M. Ueki, 18 : 178-, 1996

15 T. J. Vogl, 230 : 450-, 2004

16 Y. Zhang, 12 : 227-, 2012

17 G. S. Pancar, 13 : 138-, 2011

18 H. W. Kang, 42 : 237-, 2010

19 R. Malek, 23 : 153-, 2004

20 J. Bak, 32 : 993-, 2017

21 H. W. Kang, 17 : 118001-, 2012

22 F. M. Di Matteo, "Feasibility of EUS-guided Nd: YAG laser ablation of unresectable pan-creatic adenocarcinoma" 2018